Ergothioneine

Ergothioneine is a sulfur-containing amino acid derivative made only by fungi and a few bacteria. Humans cannot synthesize it. We get it entirely from diet, mainly mushrooms, and absorb it through OCTN1, a transporter protein so dedicated to this one molecule that researchers have proposed classifying ergothioneine as a conditionally essential nutrient rather than an optional supplement ingredient.

The strongest human data on ergothioneine is observational, not interventional. A prospective cohort study following 470 elderly participants at Singapore memory clinics for a mean of 3.7 years (up to 5 years) found that low baseline plasma ergothioneine, below a median cutoff of 784 nM, predicted greater cognitive and functional decline over the follow-up period [1]. This is cohort evidence: it shows an association between naturally low ergothioneine levels and worse outcomes, not that raising ergothioneine levels through supplementation prevents decline. A 2023 review from the University of Leeds group summarized the broader case for ergothioneine as an under-recognized dietary micronutrient, laying out the transporter biology, dietary sources, and the cohort evidence base, while stating plainly that at the time of writing there were no completed human ergothioneine intervention trials to draw on [2].

What the evidence does not show: no completed, published randomized controlled trial has tested whether ergothioneine supplementation changes any hard health outcome in humans. The one registered pilot RCT specifically designed to test this, ErgMS, a three-arm trial supplementing adults with metabolic syndrome with placebo, 5 mg/day, or 30 mg/day ergothioneine for 12 weeks, was still an unpublished study protocol as of the most recent review checked for this page, with results not yet reported [3]. That means the entire case for ergothioneine as a supplement currently rests on mushroom-consumption cohort associations and cell or animal mechanism work, not on a trial where researchers gave people the isolated compound and measured what happened.

No confirmed Blueprint page lists ergothioneine as a standing daily ingredient with a specific verified dose at the time of this review, so no self-experimentation claim from that program is attributed here.

Critics of the current ergothioneine enthusiasm point out that cohort associations between a nutrient and an outcome are routinely confounded by overall diet quality: people who eat more mushrooms likely differ from people who eat fewer mushrooms in many other health-relevant ways, and the memory-clinic cohort study cannot rule out that low ergothioneine is a marker of poor diet or poor health generally rather than a specific causal driver of cognitive decline.

The honest takeaway: ergothioneine has an unusually clean and specific delivery mechanism in the body, which makes it biologically interesting, but the evidence that supplementing with it changes a human health outcome does not yet exist as a completed, published trial.

Products with this: Ergothioneine